one hundred sixteen elderly clinic patients , independently living , ( mean age 74.3 years , range 60 to 99 years ) were taking hydrochlorothiazide ( hctz ) ( n = 40 ; mean daily dose , 53.9 mg ) , a combination of hydrochlorothiazide-triamterene ( hctz-tmtr ) ( n = 38 ; mean daily dose , 1.28 capsules ) , furosemide ( n = 20 ; mean daily dose , 38.0 mg ) , or chlorthalidone ( n = 18 ; mean daily dose , 55.6 mg ) .
C0020261
hydrochlorothiazide
C0813211
hydrochlorothiazide-triamterene